T2ND34:BVMF
Tandem Diabetes Care Inc
R$5.51
0.00%
(0.00) 1D
Oct 19, 10:41:05 AM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for T2ND34...
Open
R$5.51
High
R$5.51
Low
R$5.51
Mkt. cap
1.13B
Avg. vol.
115.00
Volume
1.00
52-wk high
R$9.93
52-wk low
R$4.33
Shares outstanding
69.58M
No. of employees
2K
Open
R$5.51
High
R$5.51
Low
R$5.51
Mkt. cap
1.13B
Avg. vol.
115.00
Volume
1.00
52-wk high
R$9.93
52-wk low
R$4.33
Shares outstanding
69.58M
No. of employees
2K
News stories
From web sources and news partners
Simply Wall Street
·
17 hours ago
Should App Recall Require Action From Tandem Diabetes Care Stock Investors?
ad-hoc-news.de
·
1 day ago
Mizuho cuts target for Tandem Diabetes Care stock from USD 20.00 to USD 18.00
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com